EASY BIO,Inc. (KOSDAQ:353810)
South Korea · Delayed Price · Currency is KRW 6,410.00
-80.00 (-1.23%)
Aug 12, 2026, 2:39 PM KST
EASY BIO,Inc. Market Cap
EASY BIO,Inc. has a market cap or net worth of 214.7 billion as of August 11, 2026. Its market cap has increased by 13.86% in one year.
Market Cap
214.70B
Enterprise Value
337.20B
Revenue
490.70B
Ranking
n/a
PE Ratio
6.43
Stock Price
6,410.00
ChartMarket Cap Chart
Since June 5, 2020, EASY BIO,Inc.'s market cap has increased from 34.76B to 214.70B, an increase of 517.71%. That is a compound annual growth rate of 34.21%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 214.70B | 11.70% |
| Dec 30, 2025 | 192.21B | 37.78% |
| Dec 30, 2024 | 139.50B | 12.89% |
| Dec 28, 2023 | 123.58B | -10.06% |
| Dec 29, 2022 | 137.40B | -14.99% |
| Dec 30, 2021 | 161.64B | -23.75% |
| Dec 18, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 5, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SillaJen | 311.75B |
| Genomictree | 311.49B |
| Proteina | 285.81B |
| BINEX | 221.02B |
| GC Cell | 219.85B |
| HLB Therapeutics | 188.38B |
| Bioneer | 178.35B |
| Anterogen.Co.,Ltd. | 169.40B |